1. Home
  2. IRON vs LRN Comparison

IRON vs LRN Comparison

Compare IRON & LRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$87.40

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo Stride Inc.

LRN

Stride Inc.

N/A

Current Price

$77.07

Market Cap

3.5B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
IRON
LRN
Founded
2017
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.5B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
IRON
LRN
Price
$87.40
$77.07
Analyst Decision
Strong Buy
Hold
Analyst Count
13
3
Target Price
★ $126.77
$102.50
AVG Volume (30 Days)
★ 1.4M
1.1M
Earning Date
11-05-2026
10-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.00
EPS
N/A
★ 1.45
Revenue
N/A
★ $917,734,000.00
Revenue This Year
N/A
$2.10
Revenue Next Year
N/A
$4.63
P/E Ratio
★ N/A
$52.97
Revenue Growth
N/A
★ 3.29
52 Week Low
$40.00
$60.61
52 Week High
$99.50
$103.67

Technical Indicators

Market Signals
Indicator
IRON
LRN
Relative Strength Index (RSI) 65.42 45.67
Support Level $65.04 $75.83
Resistance Level N/A $84.08
Average True Range (ATR) 3.82 2.81
MACD 0.55 -0.16
Stochastic Oscillator 97.64 42.47

Price Performance

Historical Comparison
IRON
LRN

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About LRN Stride Inc.

Stride Inc is a technology company providing an educational platform to deliver proprietary and third-party curriculum, software systems, and educational services designed to facilitate individualized learning for students and adults throughout the U.S. The platform delivers products and services to attract, enroll, educate, track progress, and support students. It provides customized solutions to public and private schools, school districts, charter boards, employers, government agencies, and consumers. Its platform addresses two markets in the K-12 space: General Education and Career Learning, with products and services for the General Education market predominantly focused on core subjects for kindergarten through twelfth grade students.

Share on Social Networks: